RecruitingNCT05242861
Retrospective Study of Brachytherapy
A Retrospective Study of Brachytherapy in Gynecological Cancers
Sponsor
Zhejiang Cancer Hospital
Enrollment
300 participants
Start Date
Feb 20, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Brachytherapy for gynecological cancers will be studied retrospectively.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years
Inclusion Criteria3
- female
- Underwent brachytherapy
- With gynecological cancer
Exclusion Criteria1
- Refusal to enter this trial
Interventions
RADIATIONBrachytherapy
Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05242861
Related Trials
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632154 locations
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT073185585 locations
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
NCT07213804251 locations
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT0721379127 locations
Electrochemotherapy for Recurrent Vulvar Cancer
NCT074434751 location